Appalachian Kentucky (AK) has a disproportionally high breast cancer mortality rate. Postmastectomy radiotherapy (PMRT) in N2/N3 nodal disease improves survival and locoregional recurrence. We evaluated Kentucky patient compliance to the quality measure of PMRT received within one year of diagnosis. A population-based retrospective review of patients who received mastectomy with N2/N3 nodal disease from 2006 to 2015 was obtained through the Kentucky Cancer Registry. A total of 1489 patients met the inclusion criteria. Of these, 1104 (66.6%) received PMRT. AK patients were less likely to receive PMRT (58.3%) than non-AK patients (70%, P < 0.001). After adjusting for significant factors, private insurance, education level, treatment center, and receipt of adjuvant chemotherapy were independently associated with PMRT compliance. Patients who received PMRT had improved overall survival (OS, P < 0.0001) and disease-free survival (DFS, P < 0.0001). Appalachian status was not a major factor in OS (P = 0.1929) or DFS (P = 0.5840). Nearly two decades after the recommendation of PMRT, compliance remains poor in Kentucky. PMRT continues to be a major factor in survival and recurrence in this population. Interventions focusing on improving insurance coverage, education level, and guideline adherence in nonacademic centers are needed to improve compliance.
Get full access to this article
View all access options for this article.
References
1.
YaoN., AlcalaH.E., AndersonR.Cancer disparities in rural Appalachia: incidence, early detection, and survivorship.J Rural Health2017; 33: 375–81.
2.
YaoN., LengerichE.J., HillemeierM.M.Breast cancer mortality in Appalachia: reversing patterns of disparity over time.J Health Care Poor Underserved2012; 23: 715–25.
3.
GanT., SinnerH.F., WallingS.C.Impact of the affordable care act on colorectal cancer screening, incidence, and survival in Kentucky.J Am Coll Surg2019; 228: 342–53, e341.
4.
AjkayN., BhutianiN., HuangB.Early impact of medicaid expansion and quality of breast cancer care in Kentucky.J Am Coll Surg2018; 226: 498–504.
5.
RechtA., EdgeS.B., SolinL.J.Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology.J Clin Oncol2001; 19: 1539–69.
6.
McGaleP., TaylorC., CorreaC.Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials.Lancet2014; 383: 2127–35.
7.
OvergaardM., HansenP.S., OvergaardJ.Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial.N Engl J Med1997; 337: 949–55.
RechtA., ComenE.A., FineR.E.Postmastectomy radiotherapy: an American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update.Ann Surg Oncol2017; 24: 38–51.
ChuQ.D., CalditoG., MillerJ.K.Postmastectomy radiation for N2/N3 breast cancer: factors associated with low compliance rate.J Am Coll Surg2015; 220: 659–69.
RagazJ., JacksonS.M., LeN.Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer.N Engl J Med1997; 337: 956–62.
18.
OvergaardM., JensenM.B., OvergaardJ.Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial.Lancet1999; 353: 1641–8.
19.
DragunA.E., HuangB., GuptaS.One decade later: trends and disparities in the application of post-mastectomy radiotherapy since the release of the American Society of Clinical Oncology clinical practice guidelines.Int J Radiat Oncol Biol Phys2012; 83: e591–596.
20.
MinamiC.A., BilimoriaK.Y., HansenN.M.National evaluation of the new commission on cancer quality measure for postmastectomy radiation treatment for breast cancer.Ann Surg Oncol2016; 23: 2446–55.
21.
PungliaR.S., HughesM.E., EdgeS.B.Factors associated with guideline-concordant use of radiotherapy after mastectomy in the national comprehensive cancer network.Int J Radiat Oncol Biol Phys2008; 72: 1434–40.
22.
JagsiR., AbrahamseP., MorrowM.Patterns and correlates of adjuvant radiotherapy receipt after lumpectomy and after mastectomy for breast cancer.J Clin Oncol2010; 28: 2396–403.
23.
JagsiR., AbrahamseP., MorrowM.Postmastectomy radiotherapy for breast cancer: patterns, correlates, communication, and insights into the decision process.Cancer2009; 115: 1185–93.
24.
AlbanoJ.D., WardE., JemalA.Cancer mortality in the United States by education level and race.J Natl Cancer Inst2007; 99: 1384–94.
25.
LiuY., ZhangJ., HuangR.Influence of occupation and education level on breast cancer stage at diagnosis, and treatment options in China: a nationwide, multicenter 10-year epidemiological study.Medicine2017; 96: e6641.
26.
RoyseD., DignanM.Fatalism and cancer screening in Appalachian Kentucky.Fam Community Health2011; 34: 126–33.
27.
BickellN.A., LeParF., WangJ.J.Lost opportunities: physicians’ reasons and disparities in breast cancer treatment.J Clin Oncol2007; 25: 2516–21.
28.
ShirvaniS.M., PanI.W., BuchholzT.A.Impact of evidence-based clinical guidelines on the adoption of postmastectomy radiation in older women.Cancer2011; 117: 4595–605.
29.
DragunA.E., HuangB., TuckerT.C.Disparities in the application of adjuvant radiotherapy after breast-conserving surgery for early stage breast cancer: impact on overall survival.Cancer2011; 117: 2590–8.
30.
McClellandS., KaleemT., BernardM.E.The pervasive crisis of diminishing radiation therapy access for vulnerable populations in the United States-Part 4: Appalachian patients.Adv Radiat Oncol2018; 3: 471–7.
31.
AndersonR.T., KimmickG.G., CamachoF.Health system correlates of receipt of radiation therapy after breast-conserving surgery: a study of low-income medicaid-enrolled women.Am J Manag Care2008; 14: 644–52.
32.
SamsonM.E., PorterN.G., HurleyD.M.Disparities in breast cancer incidence, mortality, and quality of care among african American and European American women in South Carolina.South Med J2016; 109: 24–30.
33.
HatzellT., RickettsT., TropmanS.Rural physicians’ understanding of the state-of-the-art in breast, colon and rectum cancer treatment.Cancer Causes Control1999; 10: 261–7.
34.
AndersonR.T., YangT.C., MatthewsS.A.Breast cancer screening, area deprivation, and later-stage breast cancer in Appalachia: does geography matter?Health Serv Res2014; 49: 546–67.
35.
CassidyR.J., LiuY., KahnS.T.The role of postmastectomy radiotherapy in women with pathologic T3N0M0 breast cancer.Cancer2017; 123: 2829–39.
